Published in J Clin Endocrinol Metab on September 01, 1992
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc Natl Acad Sci U S A (2009) 1.68
Human metabolic correlates of body mass index. Metabolomics (2014) 1.24
Effects of insulin and cytosolic redox state on glucose production pathways in the isolated perfused mouse liver measured by integrated 2H and 13C NMR. Biochem J (2006) 1.21
Aquaporin-9 protein is the primary route of hepatocyte glycerol uptake for glycerol gluconeogenesis in mice. J Biol Chem (2011) 1.04
The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest (1995) 0.87
Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review. Diabetes (2015) 0.82
Hepatic glucose production pathways after three days of a high-fat diet. Metabolism (2012) 0.82
Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nat Commun (2016) 0.78
Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes. Diabetologia (2014) 0.77
Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol (2017) 0.75
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care (2000) 4.14
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia (2009) 3.33
Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest (1987) 2.96
Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia (2006) 2.88
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes Obes Metab (2010) 2.30
Is skin preparation necessary before insulin injection? Lancet (1978) 2.15
Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia (2004) 2.12
Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med (1980) 1.96
Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest (1987) 1.83
Natural course of insulin resistance in type I diabetes. N Engl J Med (1986) 1.82
Hyperuricemia and insulin resistance. J Clin Endocrinol Metab (1994) 1.82
Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes (1987) 1.58
Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia (1999) 1.58
Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes (2001) 1.57
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia (2009) 1.53
Physiological importance of dehydroepiandrosterone. Lancet (1994) 1.49
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49
Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol (2001) 1.48
Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes (1990) 1.47
Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo. Metabolism (1994) 1.42
Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation (1997) 1.41
Guar gum in insulin-dependent diabetes: effects on glycemic control and serum lipoproteins. Am J Clin Nutr (1992) 1.40
Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia (1999) 1.40
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Physical training and insulin sensitivity. Diabetes Metab Rev (1986) 1.37
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes (1999) 1.37
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia (2007) 1.34
Increased insulin sensitivity and insulin binding to monocytes after physical training. N Engl J Med (1979) 1.33
Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia (2007) 1.31
Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest (1992) 1.30
Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes (1997) 1.30
Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes (1995) 1.30
Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension (1997) 1.30
Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med (1978) 1.27
Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation (1996) 1.26
Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest (1987) 1.25
Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia (1995) 1.25
Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab (1991) 1.24
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab (1988) 1.22
Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity. J Clin Invest (1993) 1.22
Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol (1997) 1.17
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis (1999) 1.16
Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia (1996) 1.16
Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes (1992) 1.15
Sex and insulin sensitivity. Metabolism (1984) 1.13
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes (1998) 1.11
Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis (1988) 1.11
Exercise and the metabolic syndrome. Diabetologia (1997) 1.11
Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes (1996) 1.11
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation (2000) 1.10
In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care (1999) 1.09
Glycemic control in patients with diabetes in Finland. Diabetes Care (1999) 1.08
Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest (1996) 1.07
Free fatty acid kinetics and oxidation in congestive heart failure. Am J Cardiol (1998) 1.07
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia (2004) 1.06
Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab (1984) 1.05
Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia (1991) 1.05
Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost (2001) 1.05
Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care (1998) 1.04
Structure and costs of health care of diabetic patients in Finland. Diabetes Care (1996) 1.04
Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab (1984) 1.02
Sauna-induced acceleration in insulin absorption from subcutaneous injection site. Br Med J (1980) 1.01
Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Arch Intern Med (1997) 1.01
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes. Diabetes Obes Metab (2011) 1.00
Fructose and insulin sensitivity in patients with type 2 diabetes. J Intern Med (1993) 0.99
Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation (1999) 0.99
Leptin concentration in cord blood correlates with intrauterine growth. J Clin Endocrinol Metab (1997) 0.99
Diminished wave reflection in the aorta. A novel physiological action of insulin on large blood vessels. Hypertension (1999) 0.99
Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia (1998) 0.98
Mechanisms of insulin resistance during acute endotoxemia. Endocrinology (1994) 0.98
Insulin sensitivity during the menstrual cycle. J Clin Endocrinol Metab (1984) 0.97
Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med (1993) 0.97
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care (1999) 0.97
Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes (1993) 0.97
Relationship between limb and muscle blood flow in man. J Physiol (1996) 0.97
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis (1989) 0.96
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia (2005) 0.96
Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments. Int J Obes (Lond) (2009) 0.95
Effects of body composition on insulin sensitivity. Diabetes (1983) 0.95
No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes (1991) 0.95
Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy. J Infect Dis (2009) 0.95
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology (1997) 0.95
Severity, duration, and mechanisms of insulin resistance during acute infections. J Clin Endocrinol Metab (1989) 0.95
Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett (1998) 0.95
Normalization of insulin sensitivity in type I diabetic subjects by physical training during insulin pump therapy. Diabetes Care (1985) 0.95
Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia (1995) 0.94